Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
Holding PBLA?
Track your performance easily
PBLA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.30 - $38.00
Previous Close$0.36
Volume12.34K
Average Volume (3M)7.77K
Market Cap
$1.74M
Enterprise Value$7.99M
Total Cash (Recent Filing)$142.00K
Total Debt (Recent Filing)$6.39M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Mar 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-32.52
Shares Outstanding4,854,831
10 Day Avg. Volume7,651
30 Day Avg. Volume7,767
Standard Deviation0.33
R-Squared0.02
Alpha-0.13
Financial Highlights & Ratios
Price to Book (P/B)-0.09
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Panbela Therapeutics News
PremiumCompany Announcements
Panbela Therapeutics Announces Q3 2024 Financial Results
PremiumPre-Earnings
Is PBLA a Buy, Before Earnings?
Ownership Overview
0.53%
Insiders
― Other Institutional Investors
99.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PBLA FAQ
What was Panbela Therapeutics’s price range in the past 12 months?
Panbela Therapeutics lowest stock price was $0.30 and its highest was $38.00 in the past 12 months.
What is Panbela Therapeutics’s market cap?
Currently, no data Available
When is Panbela Therapeutics’s upcoming earnings report date?
Panbela Therapeutics’s upcoming earnings report date is Mar 20, 2025 which is in 117 days.
How were Panbela Therapeutics’s earnings last quarter?
Panbela Therapeutics released its earnings results on Nov 14, 2024. The company reported -$1.48 earnings per share for the quarter, beating the consensus estimate of -$1.63 by $0.15.
Is Panbela Therapeutics overvalued?
According to Wall Street analysts Panbela Therapeutics’s price is currently Overvalued.
Does Panbela Therapeutics pay dividends?
Panbela Therapeutics does not currently pay dividends.
What is Panbela Therapeutics’s EPS estimate?
Panbela Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panbela Therapeutics have?
Panbela Therapeutics has 4,854,831 shares outstanding.
What happened to Panbela Therapeutics’s price movement after its last earnings report?
Panbela Therapeutics reported an EPS of -$1.48 in its last earnings report, beating expectations of -$1.63. Following the earnings report the stock price went up 6.667%.
Which hedge fund is a major shareholder of Panbela Therapeutics?
Currently, no hedge funds are holding shares in PBLA
---
Panbela Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-96.47%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-51.37%
Trailing 12-Months
Company Description
Panbela Therapeutics
Sun BioPharma Inc. is a clinical-stage drug development company, which engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan on September 21, 2011 and is headquartered in Waconia, MN.
---
PBLA Earnings Call
Q3 2024
0:00 / 0:00
---
PBLA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering PBLA
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-99.13%
reiterated a buy rating 11 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -99.13% per trade.
---